Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity. 2020

Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
Université de Lille, Faculté de Médecine, CHU de Lille, Laboratoire de Virologie EA3610, 59000, Lille, France.

It has been suggested that the persistence of coxsackieviruses-B (CV-B) in pancreatic beta cells plays a role in the pathogenesis of type 1 diabetes (T1D). Yet, immunological effectors, especially natural killer (NK) cells, are supposed to clear virus-infected cells. Therefore, an evaluation of the response of NK cells to pancreatic beta cells persistently infected with CV-B4 was conducted. A persistent CV-B4 infection was established in 1.1B4 pancreatic beta cells. Infectious particles were found in supernatants throughout the culture period. The proportion of cells containing viral protein VP1 was low (< 5%), although a large proportion of cells harbored viral RNA (around 50%), whilst cell viability was preserved. HLA class I cell surface expression was downregulated in persistently infected cultures, but HLA class I mRNA levels were unchanged in comparison with mock-infected cells. The cytolytic activities of IL-2-activated non-adherent peripheral blood mononuclear cells (PBMCs) and of NK cells were higher towards persistently infected cells than towards mock-infected cells, as assessed by an LDH release assay. Impaired cytolytic activity of IL-2-activated non-adherent PBMCs from patients with T1D towards infected beta cells was observed. In conclusion, pancreatic beta cells persistently infected with CV-B4 can be lysed by NK cells, implying that impaired cytolytic activity of these effector cells may play a role in the persistence of CV-B in the host and thus in the viral pathogenesis of T1D.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003384 Coxsackievirus Infections A heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis (MENINGITIS, ASEPTIC), a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia (PLEURODYNIA, EPIDEMIC) and a serious MYOCARDITIS. Coxsackie Virus Infections,Infections, Coxsackie Virus,Infections, Coxsackievirus,Coxsackie Virus Infection,Coxsackievirus Infection
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D050417 Insulin-Secreting Cells A type of pancreatic cell representing about 50-80% of the islet cells. Beta cells secrete INSULIN. Pancreatic beta Cells,beta Cells, Pancreatic,Pancreatic B Cells,B Cell, Pancreatic,B Cells, Pancreatic,Cell, Insulin-Secreting,Cells, Insulin-Secreting,Insulin Secreting Cells,Insulin-Secreting Cell,Pancreatic B Cell,Pancreatic beta Cell,beta Cell, Pancreatic
D029822 Enterovirus B, Human A species of ENTEROVIRUS infecting humans and containing 36 serotypes. It is comprised of all the echoviruses and a few coxsackieviruses, including all of those previously named coxsackievirus B. Bornholm Disease Virus,Coxsackievirus A9, Human,Echoviruses,Pleurodynia Virus,Coxsackie A9 Virus,Coxsackie B Viruses,Coxsackieviruses B,Echo Viruses,Human Coxsackievirus A9,Human Enterovirus B,Swine Vesicular Disease Virus,A9 Viruses, Coxsackie,Coxsackie A9 Viruses,Coxsackie B Virus,Disease Virus, Bornholm,Echo Virus,Echovirus,Pleurodynia Viruses,Virus, Bornholm Disease,Virus, Coxsackie A9,Virus, Coxsackie B,Viruses, Coxsackie A9

Related Publications

Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
May 2019, Viruses,
Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
February 1988, Molecular and cellular endocrinology,
Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
January 2009, European journal of immunology,
Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
October 2004, Journal of virology,
Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
January 2016, PloS one,
Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
November 1989, Molecular and cellular endocrinology,
Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
July 2011, Infection and immunity,
Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
April 2015, Antiviral research,
Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
November 2001, Journal of immunology (Baltimore, Md. : 1950),
Magloire Pandoua Nekoua, and Antoine Bertin, and Famara Sane, and Enagnon Kazali Alidjinou, and Delphine Lobert, and Jacques Trauet, and Christine Hober, and Ilka Engelmann, and Kabirou Moutairou, and Akadiri Yessoufou, and Didier Hober
March 1992, The Journal of experimental medicine,
Copied contents to your clipboard!